Annual report pursuant to Section 13 and 15(d)

Discontinued Operations - Schedule of Fair Value of Acquired Assets and Liabilities Assumed (Details)

v3.8.0.1
Discontinued Operations - Schedule of Fair Value of Acquired Assets and Liabilities Assumed (Details) - Genomas, Inc. [Member]
Sep. 27, 2017
USD ($)
Cash $ 7,990
Accounts receivable, net 6,503
Accounts payable and accrued expenses (458,736)
Deferred revenue (20,000)
Loans payable short-term (142,514)
Note payable long-term (134,118)
Total identifiable net liabilities (740,875)
Goodwill 914,972
Total consideration $ 174,097